Co-targeting of Tiam1/Rac1 and Notch ameliorates chemoresistance against doxorubicin in a biomimetic 3D lymphoma model

Lymphoma is a heterogeneous disease with a highly variable clinical course and prognosis. Improving the prognosis for patients with relapsed and treatment-resistant lymphoma remains challenging. Current in vitro drug testing models based on 2D cell culture lack natural tissue-like structural organiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikram, Muhammad, Lim, Yeseon, Baek, Sun-Yong, Jin, Songwan, Jeong, Young Hun, Kwak, Jong-Young, Yoon, Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788621/
https://www.ncbi.nlm.nih.gov/pubmed/29416753
http://dx.doi.org/10.18632/oncotarget.23156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788621/
https://www.ncbi.nlm.nih.gov/pubmed/29416753
http://dx.doi.org/10.18632/oncotarget.23156

Ejemplares similares